ATTENDEES
The Ophthalmology Innovation Summit unites Industry, Entrepreneurial and Clinical Leaders.
Below are the companies who are signed up to date to attend.
A
Acucela
Ted Danse, Chief Business Officer
Aerie Pharmaceuticals
Vince Anido, Chairman & CEO
Puiwah Braswell, Clinical Trials Manager
Eric Carlson, VP, Head, R&D
Rick Halprin, Director, Professional Affairs
Theresa Heah, VP, Clinical Research, Medical and Professional Affairs
Mark Herring, VP, Clinical Research
Cheng-Wen Lin, Director, Drug Delivery & Pharmacology
Jae Lopez, Clinical Trial Manager
Mike McCleerey, VP, Portfolio Development
Hayley McKee, Director, Clinical Research
Chyong Nien, Manager, Clinical Science
Nancy Ramirez-Davis, Director, Clinical Project Management
Richard Rubino, CFO
Huan Sheng, Director, Clinical Research & Drug Safety
Stuart Williams, Director, Research
Alcon
Paul Hallen, Global Head, Surgical Vitreoretinal & Glaucoma
Franck Leveiller, Global Head, R&D
Alimera Sciences
Rick Eiswirth, President & CFO
Dan Myers, CEO
Allegro Ophthalmics
Scott Cooper, CFO
Michele Gray, Marketing & Communications
Hampar Karageozian, CEO
Vicken Karageozian, MD, President & Chief Medical Officer
Melvin Sarayba, MD, VP, Clinical Affairs
Allergan
Tirso Alonso, Executive Medical Director
James Cunningham, Executive Director
David Nicholson, PhD, Chief R&D Officer
Allied Minds
Omar Amirana, MD, Senior Vice President
Austin Retina Associates
Robert Wong
B
Bausch + Lomb
David Fisher, VP, Marketing
Charles Hess, VP & General Manager, US Surgical
Calvin Roberts, MD, SVP & Chief Medical Officer
Bern University Hospital
Andreas Ebneter, Vitreo-Retinal Surgeon
Bionic Vision Technologies
Tamara Brawn, Head, Product Development
Julie Anne Quinn, CEO
BroadSpot Imaging
Bart Bandy, CEO & President
Brown Retina Institute
Jeremiah Brown, MD, President
Bryn Mawr Communications
Janet Burk, Publisher
Ranna Jaraha, Director of New Media
David Levine, EVP Digital & Custom Media
Karen Roman, Editor-in-Chief, Retina Today
BVI
Shervin Korangy, CFO
C
California Retina Consultants
Dante Pieramici, MD, Partner
Carl Zeiss Meditec
Kevin Langton, Director, Global ODX Professional Education
Jim Mazzo, Global President, Ophthalmic Devices
Scott Meyer, Director, Strategic Business Development
Chad Miles, National Director, US Ophthalmic Diagnostics
Angelo Rago, Global Head, Ophthalmic Diagnostics
Carle Physician Group
Michael Tsipursky, MD, Retina Specialist
Cell Care Therapeutics
Nicolas Sohl, CEO
Charles Retina Institute
Steve Charles, MD, Founder & Chairman
CheckedUp
Kyle Bechter, Director of Sponsorship Sales
Chengdu Kanghong Pharmaceutical Group
Li Liu, PhD
Associate Director, Corporate Development
ChiralLogic
Joshua Parks, Founder
Clarion Healthcare
Carol Kearney, Managing Director
Clarus
Emmett Cunningham, Jr., MD, PhD, MPH, Managing Director
Clearside Biomedical
Charlie Deignan, CFO
Carol Hoang, VP, Medical Affairs
Rick McElheny, VP, Corporate Development
Glenn Noronha, PhD, Chief Scientific Officer
Brion Raymond, Chief Commercial Officer
Daniel White, President & CEO
ClearView Healthcare Partners
Debbie Zhuang, Principal
Cole Eye Institute
Peter Kaiser, MD, Professor, Ophthalmology
Compact Imaging
Don Bogue, CEO
D
Dalton & Associates/OIS
Michelle Dalton, Contributing Writer, OIS
Davis Duehr Dean
Mitch Wolf, MD
Deerfield Management
Cameron Wheeler, Principal
DigiSight Technologies
Douglas Foster, CEO
Doheny & Stein Eye Institutes David Geffen School of Medicine at UCLA
Ali Khan, Assistant Professor of Ophthalmology
Dr. Shelley Boyd Medical Professional Corp
Shelley Boyd, MD, Director
Drusolv Therapeutics
John Edwards, CEO
E
Ethis
Etani Fajardo, Executive Director, Business Development
Luca Sergio, CEO & Owner
Mike Smolinsky, Chief Content Officer
Evolve Medical Education
Alan Guralnick, President
Evolve Therapeutics
Donald Fishbein, President
ExSight Ventures
Firas M. Rahhal, MD, Partner
Eyedaptic
Jay Cormier, CEO
EyePoint Pharmaceuticals
Leonard Blum, EVP & General Manager, U.S.
Thomas Hadley, VP, Marketing & Sales
Dario Paggiarino, MD, Chief Medical Officer
Keyur Patel, Senior Director, Medical Affairs
Josh Pettit, National Sales Manager
Michelle Poole, Senior Director, Marketing
F
ForSight Labs
Eugene de Juan, Founder & Managing Partner
Angela Macfarlane, Managing Member
Foundation Fighting Blindness
Jason Menzo, COO
G
Genentech
Anthony Adamis, MD, SVP, Global Head of Ophthalmology, Immunology, Infectious Disease & Metabolism, Clinical Science
Jason Ehrlich, MD, PhD, Global Head, Clinical Ophthalmology Product Development
Michael Verheecke, CI Manager
GenSight Biologics
Barrett Katz, MD, Chief Medical Officer
Graybug Vision
Jeffrey Cleland, PhD, President & CEO
Daniel Salain, Chief Operating Officer
Charles Semba, Chief Medical Officer
H
Heidelberg Engineering
Kfir Azoulay, VP & Head, Corporate Strategy
Kester Nahen, PhD, Managing Director
I
iBIONICS
Suzanne Grant, CEO & Co-Founder
iRenix Medical
David Robinson
Commercial Strategy Lead - Consultant
Stephen Smith
Founder & CEO
Iconic Therapeutics
William Greene, MD, CEO
InFocus Capital Partners
Ron Weiss, MD, Managing Member
InFocus Clinical
Brad Doerschuk, President, CEO
Interface Biologics
Wendy Naimark, PhD, VP, R&D
Thomas Reeves, President & CEO
InterWest Partners
Gilbert H. Kliman, MD, Managing Director
Invitae
Laura Elias, PhD, Head, Biopharma Partnerships
iRenix Medical
Stephen Smith, Founder & CEO
Istanbul Bilim University
Murat Oncel, MD, Professor, Ophthalmology
iuvo BioScience
Benjamin Burton, President & CEO
J
Janssen
Penny Fleck, CDTL
Scott Lundeen, Business Development
K
Kang Hong Pharmaceutical
Andrew Liu, VP Corporate Development
L
Leica Microsystems
Steve Milazzo, Regional Sales Manager
Lexitas
Saiid Davari, VP Investigator Relations
Siobhan Garbutt, Associate Director, Clinical Studies
Chad Ice, CEO
Michael Schiewe, Director, Strategic Programs
Lifecore Biomedical
Kipling Thacker, CSO & VP
Longitude Capital
Greg Grunberg, MD, Managing Director
M
Macuject
Devinder Chauhan, Founder
Midwest Eye Institute
Raj Maturi
Moran Eye Center, University of Utah
Paul Bernstein, MD, PhD, Professor, Ophthalmology & Visual Sciences
Multi Radiance Medical
Thomas Kelly, President
N
Needham & Co.
Serge Belanger, Analyst
Neurotech
Kenneth Mandell, MD, PhD, Chief Medical Officer
Rich Small, CEO
New England Eye Center
Caroline Baumal
Northern California Retina Vitreous Associates
Mark Wieland, MD
Northwest Eye Surgeons
Paul Griggs, MD
Notal Vision
Scott Jones, Chief Commercial Officer
Susan Orr, OD, Chief Medical Officer & VP, Medical Affairs
Quinton Oswald, CEO
Novartis
Akshay Bhargava, Manager
Fred Ellis, Head, Professional Affairs
Frederic Guerard, Head, Worldwide Business Franchise
Karen Netherton, Global Patient Access Head, Ophthalmology
Gregg Stanhope, Director, Professional Affairs
NuSight Medical
Robert Foster, CEO
O
Ocugenix
Sean McDonald, President & CEO
Alan Wells, Chief Science Advisor
Ocunexus Therapeutics
Brian Levy, CEO
ONL Therapeutics
John Freshley, President & CEO
Ophthalmology Times
Julianne Mobilian, Associate editor
Sheryl Stevenson, Group Editorial Director
Optceutics
Steve Brocchini, Co-founder & Chief Scientist
Barry Butler, Co-Founder & Business Development
Chris Redhead, CEO
P
Pacific Eye Associates / CPMC
Anne Fung, MD, Medical Retina Specialist
PANOPTiK Compliance Solutions
Jeffrey Lenk, President
Patterson Thuente
Paul Onderick, Eye Doctor & Patent Attorney
PentaVision
Jennifer Ford, Senior Managing Editor
Pepose Vision Institute
Nancy Holekamp, Director, Retinal Services
Photoswitch Therapeutics
John G. Flannery, PhD, Professor
Piper Jaffray
Jamie Adolph, Associate
Jeff Ammerman, Managing Director
Andrew Gitkin, Head, West Coast Biotechnology Investment Banking
Udit Patel, Principal, Healthcare Investment Banking
Precise Bio
Lior Shav, VP, Business Development
Promedica International
Khan Lau, Director, Clinical Operations
ProQr Therapeutics
Peter Adamson, Head, Ophthalmology Research
Daniel de Boer, CEO
R
RecensMedical
Kim Gun-Ho, CEO
Regeneron
Abby Cahn, Associate Director New Products Marketing
Karen Chu, Executive Director, Clinical Strategy and Execution, Ophthalmology
Neil Levine, Executive Director Marketing
Lucille LoTempio, PharmD, BCPS, Associate Director, Medical Affairs, Ophthalmology
John Magliocchetti, Senior Director Ophthalmology New Products Marketing
Bryce Miller, Director, Strategic Accounts
David Waintraub, Associate Manager, Ophthalmology Marketing
Retina Group of Florida
Kevin Kelly
Retina Center of Maine
Mark Balles, MD, Retina Specialist
Retina Consultants of Houston
Charles Wykoff, MD
Retina Foundation of the Southwest
Karl Csaky, MD, Managing Director & Chief Medical Officer (Also representing: T. Boone Pickens Director - Clinical Center of Innovation for AMD)
Retinal Protection Sciences
Jeffrey Luttrull, MD (Also representing: Ojai Retinal Technologies)
Retina Specialist Magazine
Rich Kirkner, Editor
Retina-Vitreous Associates Medical Group
David Boyer, MD
Retina/UCSF
Daniel Schwartz, MD, Professor
Retnia
Dominic Sauvageau, CTO
RFE Pharma
Alan Franklin, MD, PhD, Chief Medical Officer
S
Santen
Frank Chen, Innovation Project Manager
Elo Kent, Head, Global Innovation Office
Ken Shimokawa, President & Chief Investment Officer
SciFluor Life Sciences - Allied Minds
Ben Askew, VP, Research
D. Scott Edwards, PhD, VP & GM
SemaThera
John Clement, Executive Vice President
Second Sight Medical Products
Jonathan Will McGuire, President & CEO
Shire
Susan Benton, Head of Global Franchise Strategy and New Products, Ophthalmology
Robert Dempsey, Group VP & Head, Global Ophthalmics Franchise
Eric Olson, Head, Ophthalmics BD
Amir Shojaei, VP, Therapeutic Area Head - Ophthalmology Global Clinical Development
Southern California Permanente Group (Kaiser Permanente)
Vi Hau, MD, PhD, Vice-Chair Research
Spark Therapeutics
Fatima Ahmad, Medical Communications Lead
Thomas Ciulla, MD, Medical Strategy Lead, Ophthalmology
Gabrielle Dauster, Senior Product Manager
Paulo Falabella, Medical Affairs Ophthalmic Lead
Parag Meswani, PharmD, MBA, Head of Marketing and Diagnostics
Tami Smith, Head of Medical Affairs
Springfield Clinic
Ramanath Bhandari, MD
Syneos Health
Nicholas Spittal, VP, Clinical Development
T
Take One Prod.
Russell Welch, Editor
Matt Worley, Producer
Tauber Eye Center
Joseph Tauber, CEO
Texas Retina Associates
Ashkan Abbey, MD, Medical and Surgical Retinal Specialist
The Macula Center
Dana Deupree
The Wyanoke Group
Peter Slack, President
Topcon Healthcare Solutions
Tobias Kurzke, Product Manager, Clinical Applications
John Trefethen, Global Head, Marketing
Trial Runners
Brandon Beaudoin, Director, Clinical Development
Patrick Healy, MPH, Co-Founder, Executive Chairman
Kelsey McDonald, Strategic Accounts Director
Emily Murphy, Marketing Manager
TrueVision Systems
Mark Maire, EVP Sales & Business Development
U
USC Roski Eye Institute, Keck Medicine of USC
Amir H. Kashani, Assistant Professor, Clinical Ophthalmology
Houman Hemmati, Assistant Professor
University of Southern California & Los Angeles County - USC Medical Center
Grace Chang, MD, PhD, Adjunct Clinical Assistant Professor, Ophthalmology
University of Washington
Tom Reh, Professor, Department of Biological Structure
V
Vanotech
Shawn Sharon, Director
Versant Ventures
William J. Link, PhD, Managing Director
Vestrum Health
Nadeem Ahmad, Chief Operating Officer
Tom Brogan, CEO
Genevieve Lucas, Senior Director, Client Services
ViewPoint Therapeutics
Leah Makley, CEO
Visionary Venture Fund
Jeffry Weinhuff, Managing Partner
VisionCare
Blake Michaels, President & CEO
W
Wilmer Institute Johns Hopkins University School of Medicine
Susan Bressler, MD, Professor of Ophthalmology
Peter Gehlbach, MD, PhD, Professor of Ophthalmology
Z
ZeaVision Holdings
Pinakin Davey (Also Professor and Director of Research at Western University, College of Optometry)
Emily Frank, Vice President, Business Development
#
2CTech
Jim Taylor, CEO
4D Molecular Therapeutics
David Kirn, CEO & Co-Founder